Prakt. lékáren. 2011; 7(3): 116-120

Diarrhoeal diseases and their treatment

MUDr.Helena Ambrožová, PhD.
I. infekční klinika 2. LF UK a FN Na Bulovce, Praha

In the Czech Republic, diarrhoeal diseases are among the most common infectious diseases and their aetiology may be bacterial, viral,

parasitic or mycotic. The most frequent bacterial pathogens currently include campylobacters and salmonellas and there is an increasing

rate of viral diarrhoea, particularly that caused by rotavirus and norovirus. The treatment of diarrhoeal diseases primarily involves

rehydration; also essential is a low-fat diet. Symptomatic treatment may include, depending on the causative agent, adsorbents, probiotics,

antimotility drugs and/or bowel disinfectants. Antibiotic treatment is necessary only in approximately 10 % of cases, particularly

in those with a severe course, in extraintestinal disease and in immunodeficient patients.

Keywords: diarrhoea, rehydration, adsorbents, probiotics, antimotility drugs, bowel disinfectants, antibiotics

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ambrožová H. Diarrhoeal diseases and their treatment. Praktické lékárenství. 2011;7(3):116-120.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vybrané infekční nemoci v ČR v letech 2001-2010 - absolutně. Dostupné na www.szu.cz/publikace/data/infekce-v-cr.
    2. Gabarró MS, Mrukowicz J, Vesikari T, et al. Burden of rotavirus disease in European union countries. Ped Inf Dis J 2006; 25(1): 7-11. Go to original source...
    3. Patel MM, Steele D, Gentsch JR, et al. Real-world impact of rotavirus vaccination. Ped Infect Dis J 2011; 30(1): 1-5. Go to original source... Go to PubMed...
    4. Dupont Ch, Kok Foo JK, Garnier P, et al. Oral diosmec tite reduces stool output and diarrhoea duration in children with acute watery diarrhoea. Clin. Gastroenterol. Hepatol. 2009; 17(4): 456-462. Go to original source... Go to PubMed...
    5. Vesikari T, Van Damme P, Giaquinto C, et al. ESPGHAN/ESPID evidence - based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr 2008; 46(Suppl. 2): 81-118. Go to original source... Go to PubMed...
    6. Sirinavin S, Garner P. Antibiotics for treating Salmonella gut infections, Cochrane Database Syst Rev 2000: CD0001167. Go to original source...
    7. O´Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP/027 strain. Gastroenterology 2009; 138: 1913-1924. Go to original source... Go to PubMed...
    8. Sunenshine RH, McDonald LC. Clostridium difficile - associated disease: new challenges from an established pathogen. Clev Clin J Med 2006; 73(2): 187-197. Go to original source... Go to PubMed...
    9. The Campylobacter sentinel surveillance. Ciprofloxacin resistence in Campylobacter jejuni case - case analysis as a tool for elucidating risks at home and abroad. J Antimicrob Chemother 2002; 50: 361. Go to original source... Go to PubMed...
    10. Ternhag A, Asikainen T, Giesecke J, et al. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacterspecies. Clin Infect Dis, 2007; 44: 696. Go to original source... Go to PubMed...
    11. Pepin J. Vancomycin for the treatment of Clostridium difficile infection: for whom is this expensive bullet really magic? Clin Infect Dis 2008; 46: 1493-1498. Go to original source... Go to PubMed...
    12. Zar FA, Bakkanagari SR, Moorthi LST, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile - associated diarrhoea, stratified by disease severity. Clin Infect Dis 2007; 45: 302-307. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.